Johnson & Johnson (NYSE:JNJ)

127.56
BATS BZX Real-Time Price
As of 3:49pm ET
 -1.55 / -1.20%
Today’s Change
118.62
Today|||52-Week Range
148.32
-8.70%
Year-to-Date
Healthcare ETFs in Focus Following JNJ Q2 Results
10:47am / Zacks.com - Paid Partner Content
J&J's (JNJ) Phase III Study for Invokana Halted Earlier
Jul 17 / Zacks.com - Paid Partner Content
Stock Market News For Jul 18, 2018
10:33am / Zacks.com - Paid Partner Content
These Companies are Earnings All-Stars
Jul 17 / Zacks.com - Paid Partner Content
J&J (JNJ) Faces $4.69 Billion Verdict in Talc Case (Revised)
4:15am / Zacks.com - Paid Partner Content
J&J's (JNJ) Q2 Earnings Beat on Higher Cancer Drug Sales
Jul 17 / Zacks.com - Paid Partner Content
Novartis (NVS) Stock Flat Ahead of Earnings: What To Watch
Jul 17 / Zacks.com - Paid Partner Content
Watch Out For Goldman
Jul 17 / Zacks.com - Paid Partner Content
US Market Indexes Close Higher on Tuesday
Jul 17 / GuruFocus News - Paid Partner Content
Stock Market News For July 17, 2018
Jul 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close129.11
Today’s open128.80
Day’s range127.17 - 129.00
Volume323,313
Average volume (3 months)6,783,564
Market cap$338.1B
Data as of 3:49pm ET, 07/18/2018

Growth & Valuation

Earnings growth (last year)-92.07%
Earnings growth (this year)+11.29%
Earnings growth (next 5 years)+7.54%
Revenue growth (last year)+6.32%
P/E ratio276.8
Price/Sales5.02
Price/Book5.62

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.04-0.11%
NVSNovartis+2.24+2.85%
MRKMerck+0.41+0.66%
SNYSanofi+0.22+0.52%
Data as of 3:49pm ET, 07/18/2018

Financials

Next reporting dateOctober 16, 2018
EPS forecast (this quarter)$2.03
Annual revenue (last year)$76.5B
Annual profit (last year)$1.3B
Net profit margin1.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Alex Gorsky
Chief Financial Officer &
Executive Vice President
Joseph J. Wolk
Corporate headquarters
New Brunswick, New Jersey

Forecasts